All studies reported PD-L1 expression as a CPS score, which was calculated by dividing the number of PD-L1-staining cells (tumor cells, macrophages, and lymphocytes) by the total number of viable tumor cells and multiplying by 100. This evidence concerns the gene CD274 and neoplasm.